For more on the prescriber perspective, let's bring in Dr. . Kavita Patel. She's an NBC News and MSNBC medical contributor.Dr. . Patel, great to have you with us. Um, I know you wear a trader hat sometimes.Um, so it's great to get your perspective. In terms of the outperformance, we saw Novo versus Lily this week. There seems to be a real investor um, sentiment shift um, based on what happened at that conference in Vienna.And so I'm curious if from your standpoint if Novo has pulled out in front. Yeah, I th ...

Tom_Young67/iStock Unreleased via Getty Images Listen below or on the go on Apple Podcasts and Spotify ABC (DIS) pulls Jimmy Kimmel’s show off-air over Charlie Kirk remarks. (00:22) Huawei unveils new AI chip roadmap to challenge Nvidia (NVDA), plans four Ascend releases by 2028. (01:43) Krispy Kreme (DNUT) goes on a wild ride after FBI Director Kash Patel calls it a 'good investment' opportunity. (02:49) This is an abridged transcript. Jimmy Kimmel is off the air, indefinitely. Walt Disney (NYSE:DIS ...

Tom_Young67/iStock Unreleased via Getty Images Listen below or on the go on Apple Podcasts and Spotify ABC (DIS) pulls Jimmy Kimmel’s show off-air over Charlie Kirk remarks. (00:22) Huawei unveils new AI chip roadmap to challenge Nvidia (NVDA), plans four Ascend releases by 2028. (01:43) Krispy Kreme (DNUT) goes on a wild ride after FBI Director Kash Patel calls it a 'good investment' opportunity. (02:49) This is an abridged transcript. Jimmy Kimmel is off the air, indefinitely. Walt Disney (NYSE:DIS ...

Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025.Novo Nordisk said Wednesday that late-stage trial results for its once-daily obesity pill showed "significant" weight reduction and tolerability in line with its blockbuster Wegovy injection, as drugmakers race to get an oral treatment to market.Results from t ...

Novo Nordisk's experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The New England Journal of Medicine on Wednesday, which is comparable to previous trial results of injectable Wegovy. ...